Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Interferon beta-1b, ATC L03AB08 für die Zeit 01.04.2024 - 31.03.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- 1 0 1 Carefarm GmbH, Abacus Medicine A/S, axicorp Pharma GmbH, CC Pharma GmbH, EMRA-MED Arzneimittel GmbH, EurimPharm Arzneimittel GmbH, kohlpharma GmbH, Medicopharm AG, Orifarm GmbH, Originalis B.V.
- Contract value
- no value published
- Bids received
- 7
- Published
- 15 Jun 2026
- Awarded
- 1 Apr 2024
- Contract start
- 1 Apr 2024
- Contract end
- 14 Apr 2025estimated
- Region
- Hamburg